MedTrace Logo

Supporting Caregivers Following Mental Health Emergency Department Visits

NCT07411300 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2026-02-13

No results posted yet for this study

Summary

The investigators plan to conduct a pilot hybrid effectiveness-implementation type 1 randomized controlled trial comparing 3 arms of varying follow-up intervention. Caregivers of youth ages 10-17 who present to the Lurie Children's Hospital ED with suicidal thoughts or behaviors (STBs) and are discharged with a safety plan will be included in the current study. Families will be randomized to receive either 1) treatment as usual, 2) follow-up phone calls, or 3) automatic electronic medical record (EMR) MyChart messages

Conditions

  • Caregiver Participation
  • Emergency Department Presentation
  • Safety Plan

Interventions

BEHAVIORAL

Telephone Calls

Parents/guardians are contacted via telephone by a psychiatric social worker within 72 hours of ED discharge, then the family receives weekly phone calls until either they have successfully connected to follow-up mental health services or asks to no longer be contacted. Otherwise phone calls will continue to be made weekly until 60-days post-discharge.

BEHAVIORAL

Automatic MyChart Messages

Parents/guardians receive automatic MyChart messages within 72 hours of ED discharge, then the family receives weekly messages until 60-days post-discharge.

Sponsors & Collaborators

  • Health Resources and Services Administration (HRSA)

    collaborator FED

  • Ann & Robert H Lurie Children's Hospital of Chicago

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-26
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07411300 on ClinicalTrials.gov